uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted September 08, 2012

Medifast Settles False Advertising Suit

On September 7, 2012, Jason Pharmaceuticals Inc., a wholly owned subsidiary of Medifast, agreed to pay a $3.7 million civil penalty and meet new compliance requirements as part of a settlement with the U.S. Department of Justice and the Federal Trade Commission.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at